New perspectives for the development of selective metabotropic glutamate receptor ligands

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 277-294

  Pin, Jean Philippe ^a   De Colle, Cyril ^c   Bessis, Anne Sophie ^b   Acher, Francine ^b  

^a INSERM   (France)

^b CNRS   (France)

^c Institut de Recherche Jouveinal   (France)

Author keywords

G protein coupling domain; Metabotropic glutamate receptor ligand; Molecular modeling; Neuroactive molecule; Receptor activation; Regulating site

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; IONOTROPIC RECEPTOR; LIGAND; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARTIAL AGONIST; QUISQUALIC ACID; RECEPTOR SUBTYPE;

BINDING SITE; DRUG DEVELOPMENT; DRUG STRUCTURE; MOLECULAR MODEL; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0033057319     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00258-7     Document Type: Review

References (109)

1. Acher F., Tellier F., Azerad R., Brabet I., Fagni L., Pin J.-P. Synthesis and pharmacological characterization of aminocyclopentane tricarboxylic acids (ACPT): new tools to discriminate between metabotropic glutamate receptor subtypes. J. Med. Chem. 40:1997;3119-3129.
2. Ahmadian H., Nielsen B., Bräuner-Osborne H., Johansen T.N., Stensbøl T.B., Sløk F.A., Sekiyama N., Nakanishi S., Krogsgaard-Larsen P., Madsen U. (S)-Homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors. J. Med. Chem. 40:1997;3700-3705.
3. Alaluf S., Mulvihill E.R., McIlhinney R.A.J. Rapid agonist mediated phosphorylation of the metabotropic glutamate receptor 1α by protein kinase C in permanently transfected BHK cells. FEBS Lett. 367:1995;301-305.
4. Annoura H., Fukunaga A., Uesugi M., Tatsuoka T., Horikawa Y. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates. Bioorg. Med. Chem. Lett. 6:1996;763-766.
5. Armstrong N., Sun Y., Chen G.Q., Gouaux E. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature. 395:1998;913-917.
6. Bai M., Trivedi S., Brown E.M. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J. Biol. Cell. 273:1998;23605-23610.
7. Baker S.R., Clark B., Harris J., Griffy K., Kingston A., Tizzano J. LY393675, an α-substituted-cyclobutylglycine, is a potent group-I metabotropic glutamate receptor antagonist. Soc. Neurosci. Abstr. 24:1998;576.
8. Barker E.L., Westphal R.S., Schmidt D., Sanders-Bush E. Constitutive active 5-hydroxytryptamine 2c receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269:1994;11687-11690.
9. Bessis, A.-S., Jullian, N., Coudert, E., Pin, J.-P., Acher, F., 1999. Extended glutamate activates metabotropic receptor types 1, 2 and 4: selective features at mGluR4 binding site. Neuropharmacology, in press.
10. Blahos J. II, Mary S., Perroy J., de Colle C., Brabet I., Bockaert J., Pin J.-P. Extreme C-terminus of G-protein α-subunits contains a site that discriminates between Gi-coupled metabotropic glutamate receptors. J. Biol. Chem. 273:1998;25765-25769.
11. Bockaert J., Pin J.-P. Molecular tinkering of G-protein coupled receptors: an evolutionary success. EMBO J. 18:1999;1723-1729.
12. Bond A., Oneill M.J., Hicks C.A., Monn J.A., Lodge D. Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. NeuroReport. 9:1998;1191-1193.
13. Bourne H.R. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9:1997;134-142.
14. Brabet I., Parmentier M.-L., Bockaert J., Acher F., Pin J.-P. Comparative effect of L-CCG-I, DCG-IV and γ-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes. Neuropharmacology. 37:1998;1043-1051.
15. Brakeman P.R., Lanahan A.A., O'Brien R.J., Roche K., Barnes C.A., Huganir R.L., Worley P.F. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature. 286:1997;284-288.
16. Brauner-Osborne H., Krogsgaard-Larsen P. Pharmacology of (S)-homoquisqualic acid and (S)-2-amino-5-phosphonopentanoic acid [(S)-AP5] at cloned metabotropic glutamate receptors. Br. J. Pharmacol. 123:1998;269-274.
17. Bräuner-Osborne H., Madsen U., Mikiciuk-Olasik E., Curry K. New analogues of ACPD with selective activity for group II metabotropic glutamate receptors. Eur. J. Pharmacol. 332:1997;327-331.
18. Brauner-Osborne H., Nielsen B., Krogsgaard-Larsen P. Molecular pharmacology of homologues of ibotenic acid at cloned metabotropic glutamic acid receptors. Eur. J. Pharmacol. 350:1998;311-316.
19. Cartmell J., Adam G., Chaboz S., Henningsen R., Kemp J.A., Klingelschmidt A., Metzler V., Monsma F., Schaffhauser H., Wichmann J., Mutel V. Characterization of [H-3]-(2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine ([H-3]-DCG IV) binding to metabotropic mGlu(2) receptor-transfected cell membranes. Br. J. Pharmacol. 123:1998;497-504.
20. Clark B.P., Baker S.R., Goldsworthy J., Harris J.R., Kingston A.E. (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorg. Med. Chem. Lett. 7:1997;2777-2780.
21. Conn P., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol. 37:1997;205-237.
22. Contractor A., Gereau R.W.t., Green T., Heinemann S.F. Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8969-8974.
23. Corti C., Restituito S., Rimland J.M., Brabet I., Corsi M., Pin J.-P., Ferraguti F. Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8. Eur. J. Neurosci. 10:1998;3629-3641.
24. Costantino G., Pellicciari R. Homology modeling of metabotropic glutamate receptors. (mGluRs) Structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists. J. Med. Chem. 39:1996;3998-4006.
25. Costantino G., Natalini B., Pellicciari R. Definition of a pharmacophore for the metabotropic glutamate receptors negatively linked to adenylyl cyclase. Bioorg. Med. Chem. 1:1993;259-265.
26. Doherty A.J., Palmer M.J., Henley J.M., Collingridge G.L., Jane D.E. (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu(5), but not mGlu(1), receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology. 36:1997;265-267.
27. Escribano A., Ezquerra J., Pedregal C., Rubio A., Yrurelagoyena B., Baker S.R., Wright R., Johnson B.G., Schoepp D.D. (2S,4S)-2-amino-4-(2,2-diphenylethyl)pentanedioic acid selective group 2 metabotropic glutamate receptor antagonist. Bioorg. Med. Chem. Lett. 8:1998;765-770.
28. +-channel by stimulation of glutamate phosphoinositide-coupled receptors in cultured cerebellar granule cells. Eur. J. Neurosci. 3:1991;778-789.
29. 2+ receptor: effects on cell surface expression, dimerization and signal transduction. FEBS Lett. 436:1998;353-356.
30. Fiorillo C.D., Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurones. Nature. 394:1998;78-82.
31. Flor P.J., Vanderputten H., Ruegg D., Lukic S., Leonhardt T., Bence M., Sansig G., Knopfel T., Kuhn R. A novel splice variant of a metabotropic glutamate receptor, human mGluR7b. Neuropharmacology. 36:1997;153-159.
32. Francesconi A., Duvoisin R.M. Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J. Biol. Chem. 273:1998;5615-5624.
33. Galvez T., Parmentier M.-L., Joly C., Malitschek B., Kaupmann K., Kuhn R., Bittiger H., Froestl W., Bettler B., Pin J.-P. Mutagenesis and modeling of the GABA-B receptor binding site suggest a Venus Fly-trap mechanism for ligand binding. J. Biol. Chem. 274:1999;13362-13369.
34. Gasparini F., Bruno V., Battaglia G., Lukic S., Leonhardt T., Inderbitzin W., Laurie D., Sommer B., Varney M., Hess S.D., Johnson E.C., Kuhn R., Urwyler S., Sauer D., Portet C., Schmutz M., Nicoletti F., Flor P.J. (RS)-PPG, a potent and selective group-III metabotropic glutamate receptor agonist is anticonvulsive and neuroprotective in vivo. J. Pharmacol. Exp. Ther. 289:1999;. in press.
35. Gasparini, F., Lingenhoehl, K., Flor, P.J., Munier, N., Heinrich, M., Vranesic, I., Biollaz, M., Heckendorn, R., Allgeier, H., Varney, M.A., Johnson, E., Hess, S.D., Veliçelebi, G., Kuhn, R., 1999b. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP): a novel potent, subtype-selective and systemically active antagonist at metabotropic glutamate receptor subtype 5. BPS meeting abstracts, in press.
36. Gereau R.W., Conn P.J. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. J. Neurosci. 15:1995;6879-6889.
37. Gereau R.W.t., Heinemann S.F. Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5. Neuron. 20:1998;143-151.
38. Gomeza J., Joly C., Kuhn R., Knöpfel T., Bockaert J., Pin J.-P. The second intracellular loop of mGluR1 cooperates with the other intracellular domains to control coupling to G-protein. J. Biol. Chem. 271:1996;2199-2205.
39. Gomeza J., Mary S., Brabet I., Parmentier M.-L., Restituito S., Bockaert J., Pin J.-P. Coupling of mGluR2 and mGluR4 to Gα15, Gα16 and chimeric Gαq/i proteins: characterization of new antagonists. Mol. Pharmacol. 50:1996;923-930.
40. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol. Pharmacol. 53:1998;1083-1088.
41. 2+ receptors. Mol. Pharmacol. 55:1999;642-648.
42. Han G., Hampson D.R. Ligand binding to the amino terminal domain of the mGlurR4 subtype of metabotropic glutamate receptor. J. Biol. Chem. 274:1999;10008-10013.
43. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., Bouvier M. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271:1996;16384-16392.
44. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. Neuropharmacology. 36:1997;1511-1516.
45. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J. Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 284:1998;651-660.
46. Hermans E., Nahorski S.R., Challiss R.A.J. Reversible and non-competitive antagonist profile of CPCCOEt at the human. Neuropharmacology. 37:1998;1645-1647.
47. Herrero I., Miras-Portugal M.T., Sanchez-Prieto J. Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors. J. Biol. Chem. 273:1998;1951-1958.
48. Jane D.E., Thomas N.K., Tse H.-W., Watkins J.C. Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Neuropharmacology. 35:1996;1029-1035.
49. Johansen P.A., Chase L.A., Sinor A.D., Koerner J.F., Johnson R.L., Robinson M.B. Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats. Mol. Pharmacol. 48:1995;140-149.
50. Joly C., Gomeza J., Brabet I., Curry K., Bockaert J., Pin J.-P. Molecular, functional and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J. Neurosci. 15:1995;3970-3981.
51. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.-J., Johnson M., Gunwaldsen C., Huang L.-Y., Tang C., Shen Q., Salon J.A., Morse K., Laz T., Smith K.E., Nagarathnam D., Noble S.A., Branchek T.A., Gerald C. GABA B receptors function as a heteromeric assembly of the subunits GABA B R1 and GABA B R2. Nature. 396:1998;674-679.
52. Jullian, N., Brabet, I., Pin, J.-P., Acher, F.C., 1999. Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation. J. Med. Chem., in press.
53. Kato A., Ozawa F., Saitoh Y., Fukazawa Y., Sugiyama H., Inokuchi K. Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J. Biol. Chem. 273:1998;23969-23975.
54. Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P., Mosbacher J., Bishoff S., Kulik A., Shigemoto R., Karschin A., Bettler B. GABA B-receptor subtypes assemble into functional heteromeric complexes. Nature. 396:1998;683-687.
55. Kawabata S., Tsutsumi R., Kohara A., Yamaguchi T., Nakanishi S., Okada M. Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors. Nature. 383:1996;89-92.
56. Kingston A., Lowndes J., Evans N., Clark B., Tomlinson R., Burnett J., Mayne N., Cockerham S., Lodge D. Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell lines. Neuropharmacology. 37:1998;277-287.
57. Kingston A.E., Ornstein P.L., Wright R.A., Johnson B.G., Mayne N.G., Burnett J.P., Belagaje R., Wu S., Schoepp D.D. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology. 37:1998;1-12.
58. Konieczny J., Ossowska K., Wolfarth S., Pilc A. LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats. Naunyn Schmiedebergs Arch. Pharmacol. 358:1998;500-502.
59. Kozikowski A.P., Steensma D., Araldi G.L., Tückmantel W., Wang S., Pshenichkin S., Surina E., Wroblewski J.T. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist. J. Med. Chem. 41:1998;1641-1650.
60. 2+-sensing function of the metabotropic glutamate receptors. Science. 279:1998;1722-1725.
61. Kuner R., Kohe G., Grünewald S., Eisenhardt G., Bach A., Kornau H.C. Role of heteromer formation in GABAB receptor function. Science. 283:1999;74-77.
62. Litschig S., Gasparini F., Rueegg D., Munier N., Flor P.J., Vranesic I.-T., Prézeau L., Pin J.-P., Thomsen C., Kuhn R. CPCCOEt, a non-competitive mGluR1 antagonist, inhibits receptor signaling without affecting glutamate binding. Mol. Pharmacol. 55:1998;453-461.
63. Lerma J., Morales M., Vicente M.A., Herreras O. Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci. 20:1997;9-12.
64. Ma D.W., Tian H.Q., Sun H.B., Kozikowski A.P., Pshenichkin S., Wroblewski J.T. Synthesis and biological activity of cyclic analogues of MPPG and MCPG as metabotropic glutamate receptor antagonists. Bioorg. Med. Chem. Lett. 7:1997;1195-1198.
65. Maggio R., Vogel Z., Wess J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular 'cross-talk' between G-protein-linked receptors. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3103-3107.
66. B receptors is sufficient to specify agonist and antagonist binding. Mol. Pharmacol., in press.
67. Manzoni O., Castillo P.E., Nicoll R.A. Agonist pharmacology of metabotropic glutamate receptors at the mossy fiber synapses of the guinea pig hippocampus. Neuropharmacology. 34:1995;965-971.
68. Mary S., Gomeza J., Prézeau L., Bockaert J., Pin J.-P. A cluster of basic residues in the carboxy-terminal tail of the short mGluR1 variants impairs their coupling to PLC. J. Biol. Chem. 273:1998;425-432.
69. Minakami R., Jinnai N., Sugiyama H. Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro. J. Biol. Chem. 272:1997;20291-20298.
70. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 28:1998;1349-1352.
71. Monn J.A., Valli M.J., Andis S.L., Wright R.A., Johnson B.G., Tomlinson R., Kingston A.E., Schoepp D.D. In vitro characterization of LY379268: a highly potent and selective agonist for group-II metabotropic glutamate receptors. Soc. Neurosci. Abstr. 24:1998;583.
72. Monnot C., Bihoreau C., Conchon S., Curnow K.M., Corvol P., Clauser E. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem. 271:1996;1507-1513.
73. Mulle C., Sailer A., Perez-Otano I., Dickinson-Anson H., Castillo P.E., Bureau I., Maron C., Gage F.H., Mann J.R., Bettler B., Heinemann S.F. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature. 392:1998;601-605.
74. Nemeth E., Steffey M., Hammerland L., Hung B., Van Wagenen B., DelMar E., Balandrin M. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc. Natl. Acad. Sci. U.S.A. 95:1998;4040-4045.
75. O'Hara P.J., Sheppard P.O., Thøgersen H., Venezia D., Haldeman B.A., McGrane V., Houamed K.M., Thomsen C., Gilbert T.L., Mulvihill E.R. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron. 11:1993;41-52.
76. Okamoto T., Sekiyama N., Otsu M., Shimada Y., Sato A., Nakanishi S., Jingami H. Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. 273:1998;13089-13096.
77. 3H ]LY341495, a highly potent, selective and novel radioligand for labeling group-II metabotropic glutamate receptors Bioorg. Med. Chem. Lett. 8:1998;1919-1922.
78. Parmentier M.-L., Pin J.-P., Bockaert J., Grau Y. Cloning and functional expression of a Drosophila metabotropic glutamate receptor expressed in the embryonic central nervous system. J. Neurosci. 16:1996;6687-6694.
79. Parmentier M.L., Joly C., Restituito S., Bockaert J., Grau Y., Pin J.-P. The G-protein coupling profile of metabotropic glutamate receptors, as determined with exogenous G-proteins, is independent of their ligand recognition domain. Mol. Pharmacol. 53:1998;778-786.
80. Pellicciari R., Raimondo M., Marinozzi M., Natalini B., Costantino G., Thomsen C. (S)-(+)-2-(3′-carboxybicyclo[1.1.1]pentyl)glycine, a structurally new group I metabotropic glutamate receptor antagonist. J. Med. Chem. 39:1996;2874-2876.
81. Pellicciari R., Costantino G., Giovagnoni E., Mattoli L., Brabet I., Pin J.-P. Synthesis and preliminary evaluation of (S)-2-(4′-carboxycubyl)glycine, a new selective mGluR1 antagonist. Bioorg. Med. Chem. Lett. 8:1998;1569-1574.
82. 3H ]glutamate binding: a new receptor or a particular transport process? FEBS Lett. 175:1984;31-36.
83. Pin J.-P., Joly C., Heinemann S.F., Bockaert J. Domains involved in the specificity of G protein activation in phospholipase C coupled metabotropic glutamate receptor. EMBO J. 13:1994;342-348.
84. Prézeau L., Gomeza J., Ahern S., Mary S., Galvez T., Bockaert J., Pin J.-P. Changes of the C-terminal domain of mGluR1 by alternative splicing generate receptors with different agonist independent activity. Mol. Pharmacol. 49:1996;422-429.
85. Quiocho F.A. Atomic structures of periplasmic binding proteins and the high-affinity active transport systems in bacteria. Philos. Trans. R. Soc. Lond. B. 326:1990;341-351.
86. Romano C., Yang W.-L., O'Malley K.L. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 271:1996;28612-28616.
87. 2+ on type 1alpha metabotropic glutamate receptor-mediated signalling. Neuropharmacology. 37:1998;273-276.
88. 3H ]LY354740, in rat brain Mol. Pharmacol. 53:1998;228-233.
89. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Mayne N.G., Wu S., Cockerham S.L., Burnett J.P., Belegaje R., Bleakman D., Monn J.A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology. 36:1997;1-11.
90. Shigemoto R., Kulik A., Roberts J.D.B., Ohishi H., Nusser Z., Kaneko T., Somogyi P. Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone. Nature. 381:1996;523-525.
91. Stowell J.N., Craig A.M. Axon/dendrite targeting of metabotropic glutamate receptor y their cytoplasmic carboxy-terminal domains. Neuron. 22:1998;525-536.
92. Takahashi K., Tsuchida K., Tanabe Y., Masu M., Nakanishi S. Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination. J. Biol. Chem. 268:1993;19341-19345.
93. Tellier F., Acher F., Brabet I., Pin J.-P., Azerad R. Aminobicyclo[2.2.1.]heptane dicarboxylic acids (ABHD), analogs of ACPD and glutamic acid: synthesis and pharmacological activity on metabotropic receptors mGluR1a and mGluR2. Bioorg. Med. Chem. 6:1998;195-208.
94. Thomsen C., Mulvihill E.R., Haldeman B., Pickering D.S., Hampson D.R., Suzdak P.D. A pharmacological characterization of the mGluR1α subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line. Brain Res. 619:1993;22-28.
95. Thomsen C., Bruno V., Nicoletti F., Marinozzi M., Pellicciari R. (2S,1′S,2′S,3′R)-2-(2′-carboxy-3′- phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors. Mol. Pharmacol. 50:1996;6-9.
96. Tones M.A., Bendali H., Flor P.J., Knopfel T., Kuhn R. The agonist selectivity of a class III metabotropic glutamate receptor, human mGluR4a, is determined by the N-terminal extracellular domain. NeuroReport. 7:1995;117-120.
97. Tu J.C., Xiao B., Yuan J.P., Lanahan A.A., Leoffert K., Li M., Linden D.J., Worley P.F. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron. 21:1998;717-726.
98. Tückmantel W., Kozikowski A.P., Wang S., Pshenichkin S., Wroblewski J.T. Synthesis, molecular modeling, and biology of the 1-benzyl derivative of APDC - an apparent mGluR6 selective ligand. Bioorg. Med. Chem. Lett. 7:1997;601-606.
99. Valli M.J., Schoepp D.D., Wright R.A., Johnson B.G., Kingston A.E., Tomlinson R., Monn J.A. Synthesis and metabotropic glutamate receptor antagonist activity of N1-substituted analogs of 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic acid. Bioorg. Med. Chem. Lett. 8:1998;1985-1990.
100. Van Wagenen B., Artman L., Hammerland L., Hung B., Johnson J., Krapcho K., Levinthal C., Logan M., Moe S., Mueller A., Simin R., Smith D., Storjohann L., Stormann T. In vitro pharmacological characterizations of NPS2390: a highly potent and selective, non-competitive antagonist of group-I metabotropic glutamate receptors. Soc. Neurosci. Abstr. 24:1998;576.
101. Varney, M.A., Cosford, N., Jachec, C., Rao, S., Sacaan, A., Santori, E., Allgeier, H., Gasparini, F., Flor, P.J., Kuhn, R., Hess, S.D., Veliçelebi, G., Johnson, E., 1999. Characterization of SIB-1757 and SIB-1893: highly selective antagonists at metabotropic glutamate receptor subtype 5. BPS meeting abstracts, in press.
102. Ward D.T., Brown E.M., Harris H.W. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J. Biol. Chem. 273:1998;14476-14483.
103. Wermuth C.G., Mann A., Schoenfelder A., Wright R.A., Johnson B.G., Burnett J.P., Mayne N.G., Schoepp D.D. (2S,4S)-2-Amino-4-(4,4-diphenylbut-1-yl)-pentane-1.5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase. J. Med. Chem. 39:1996;814-816.
104. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 11:1997;346-354.
105. White J.H., Alan W., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord S.M., Marshall F.H. Heterodimerisation is required for the formation of a functional GABA B receptor. Nature. 396:1998;679-682.
106. Wroblewska B., Wroblewski J.T., Pshenichkin S., Surin A., Sullivan S.E., Neale J.H. N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69:1997;174-181.
107. Wu S., Wright R.A., Rockey P.K., Burgett S.G., Arnold J.S., Rosteck P.R. Jr., Johnson B.G., Schoepp D.D., Belagaje R.M. Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells. Brain Res. Mol. Brain Res. 53:1998;88-97.
108. Xiao B., Tu J.C., Petralia R.S., Yuan J.P., Doan A., Breder C.D., Ruggiero A., Lanahan A.A., Wenthold R.J., Worley P.F. Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of Homer-related, synaptic proteins. Neuron. 21:1998;707-716.
109. Yang P., Chaney M., Baez M. Mutagenesis analysis of a human mGluR2 binding site model using a novel tritiated antagonist, LY341495, as a probe. Soc. Neurosci. Abstr. 24:1998;1343.